J.P.D. Reckless

1.2k total citations
41 papers, 842 citations indexed

About

J.P.D. Reckless is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, J.P.D. Reckless has authored 41 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in J.P.D. Reckless's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Diabetes Management and Research (6 papers). J.P.D. Reckless is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Diabetes Management and Research (6 papers). J.P.D. Reckless collaborates with scholars based in United Kingdom, United States and Malta. J.P.D. Reckless's co-authors include Ian McColl, Graham W. Taylor, D. J. Betteridge, D. J. Galton, David Weinstein, Daniel Steinberg, K.I. Williams, K.E.H. El Tahir, Anthony D. Kelleher and D. R. Cullen and has published in prestigious journals such as The Lancet, The American Journal of Medicine and Diabetologia.

In The Last Decade

J.P.D. Reckless

38 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P.D. Reckless United Kingdom 16 357 307 208 141 115 41 842
Yumi Miyashita Japan 22 281 0.8× 233 0.8× 416 2.0× 132 0.9× 136 1.2× 48 1.2k
J. A. Weaver United Kingdom 20 218 0.6× 644 2.1× 72 0.3× 175 1.2× 134 1.2× 45 1.1k
Mikio Okamura Japan 17 194 0.5× 385 1.3× 106 0.5× 112 0.8× 196 1.7× 40 1.2k
D. Wile United Kingdom 14 424 1.2× 464 1.5× 306 1.5× 132 0.9× 198 1.7× 20 1.0k
R.S. Elkeles United Kingdom 18 316 0.9× 502 1.6× 114 0.5× 251 1.8× 127 1.1× 55 1.1k
M. L. Caramori United States 10 192 0.5× 578 1.9× 118 0.6× 249 1.8× 191 1.7× 14 1.2k
P. T. Sawicki Germany 20 255 0.7× 764 2.5× 135 0.6× 346 2.5× 414 3.6× 46 1.4k
F Lamotte France 6 286 0.8× 509 1.7× 123 0.6× 733 5.2× 143 1.2× 10 1.2k
R Mahler United Kingdom 11 198 0.6× 222 0.7× 56 0.3× 94 0.7× 213 1.9× 38 799
C Iovine Italy 14 194 0.5× 407 1.3× 61 0.3× 276 2.0× 127 1.1× 30 909

Countries citing papers authored by J.P.D. Reckless

Since Specialization
Citations

This map shows the geographic impact of J.P.D. Reckless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P.D. Reckless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P.D. Reckless more than expected).

Fields of papers citing papers by J.P.D. Reckless

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P.D. Reckless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P.D. Reckless. The network helps show where J.P.D. Reckless may publish in the future.

Co-authorship network of co-authors of J.P.D. Reckless

This figure shows the co-authorship network connecting the top 25 collaborators of J.P.D. Reckless. A scholar is included among the top collaborators of J.P.D. Reckless based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P.D. Reckless. J.P.D. Reckless is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simpson, Emma, Patrick Fitzgerald, Peter William Evans, et al.. (2013). Bivalirudin for the Treatment of ST-Segment Elevation Myocardial Infarction: A NICE Single Technology Appraisal. PharmacoEconomics. 31(4). 269–275. 12 indexed citations
2.
Brown, Jenny, J. Broom, Rachel Laws, et al.. (2008). The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change. Obesity Research & Clinical Practice. 2(1). 15–27. 17 indexed citations
3.
Reckless, J.P.D. & Jane M. Morrell. (2005). Lipid disorders : your questions answered. Elsevier eBooks.
4.
Mukhtar, Rasha & J.P.D. Reckless. (2005). Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone. Diabetic Medicine. 22(s3). 6–10. 9 indexed citations
5.
Reckless, J.P.D.. (2000). Cost-effectiveness of statins. Current Opinion in Lipidology. 11(4). 351–356. 8 indexed citations
6.
Kozka, I J, A E Clark, J.P.D. Reckless, et al.. (1995). The effects of insulin on the level and activity of the GLUT4 present in human adipose cells. Diabetologia. 38(6). 661–666. 30 indexed citations
7.
Gold, Ann E., Ian J. Deary, Roy Jones, et al.. (1994). Severe Deterioration in Cognitive Function and Personality in Five Patients with Long‐standing Diabetes: A Complication of Diabetes or a Consequence of Treatment?. Diabetic Medicine. 11(5). 499–505. 41 indexed citations
8.
Reckless, J.P.D., et al.. (1994). Generalised lipodystrophy and pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 101(8). 719–720. 3 indexed citations
9.
Betteridge, D. J., Paul N. Durrington, George S. Jackson, et al.. (1994). Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia. The American Journal of Medicine. 96(6). S45–S54. 19 indexed citations
10.
Kelleher, Anthony D., et al.. (1992). Screening Programme for Microvascular Complications and Hypertension in a Community Diabetic Population. Diabetic Medicine. 9(6). 550–556. 13 indexed citations
11.
Kelleher, Anthony D., et al.. (1991). Detection of Diabetic Retinopathy in the Community Using a Non‐mydriatic Camera. Diabetic Medicine. 8(6). 551–555. 41 indexed citations
12.
Hewett, Sandra J., et al.. (1990). Isoform Patterns of Apolipoprotein E in Diabetes Mellitus. Diabetic Medicine. 7(6). 532–539. 12 indexed citations
13.
Simpson, H.C.R., et al.. (1990). Combination of Insulin with Glipizide Increases Peripheral Glucose Disposal in Secondary Failure Type 2 Diabetic Patients. Diabetic Medicine. 7(2). 143–147. 17 indexed citations
14.
Reckless, J.P.D., et al.. (1989). Proliferative Diabetic Retinopathy in a Patient with Maturity‐onset Diabetes of the Young (MODY). Diabetic Medicine. 6(5). 451–453. 5 indexed citations
15.
Reckless, J.P.D.. (1987). Can nutrition favourably affect serum lipids?. Proceedings of The Nutrition Society. 46(3). 361–366. 5 indexed citations
16.
Howell, Susan, K J Foster, & J.P.D. Reckless. (1983). Protracted survival in patients with Down's syndrome.. BMJ. 287(6403). 1429.2–1430. 14 indexed citations
17.
Potter, J., J.P.D. Reckless, & D. R. Cullen. (1980). Subcutaneous continuous insulin infusion and control of blood glucose concentration in diabetics in third trimester of pregnancy.. BMJ. 280(6222). 1099–1101. 15 indexed citations
18.
Reckless, J.P.D. & D. J. Galton. (1980). Peripheral Resistance to the Cellular Action of Insulin in Obese Diabetic Subjects In Vivo. Clinical Science. 58(1). 59–63. 3 indexed citations
19.
Reckless, J.P.D., et al.. (1978). High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus.. BMJ. 1(6117). 883–886. 93 indexed citations
20.
Reckless, J.P.D., Ian McColl, & Graham W. Taylor. (1972). Aorto-Caval Fistulae: An Uncommon Complication of Abdominal Aortic Aneurysms. British journal of surgery. 59(6). 461–462. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yumi Miyashita Breakdown of academic impact, for papers by J. A. Weaver Breakdown of academic impact, for papers by Mikio Okamura Breakdown of academic impact, for papers by D. Wile Breakdown of academic impact, for papers by R.S. Elkeles Breakdown of academic impact, for papers by M. L. Caramori Breakdown of academic impact, for papers by P. T. Sawicki Breakdown of academic impact, for papers by F Lamotte Breakdown of academic impact, for papers by R Mahler Breakdown of academic impact, for papers by C Iovine
Rankless by CCL
2026